EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteome Profiling Reveals NQO2 Activity Contributing to Proteasome Inhibitor Resistance in Multiple Myeloma Cell Lines

Chien-Yun Lee, Seungbin Han, Larissa Haertle, Umair Munawar, Cornelia Vogt, Johanna Streubel, Andrej Besse, Lenka Besse, Christoph Driessen, Hermann Einsele, Johannes Waldschmidt, Martin Kortüm und 1 weitere

Molecular & Cellular Proteomics · 2026-08 · 25 (8) · 101615

DOI: 10.1016/j.mcpro.2026.101615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2026-08. Verfasst von Chien-Yun Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Proteomics and Bioanalytics, School of Life Sciences, Technical University of Munich, Freising, Germany. Hauptthemen laut MEDLINE: Multiple Myeloma, Drug Resistance, Neoplasm, Proteasome Inhibitors, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteasome inhibitors (PIs) are frontline therapies for multiple myeloma (MM). Although MM patients initially respond to PIs, resistance frequently emerges. While all PIs nominally target the same proteasomal catalytic subunit (PSMB5), the extent to which resistance mechanisms are the same or different among different PIs or between patients is poorly understood. To address this, we performed proteome and phosphoproteome profiling of 12 MM cell line models, comprising four parental lines (AMO-1, ARH77, L363, and RPMI8226) paired with lines that acquired resistance to bortezomib (BTZ) or carfilzomib (CFZ). Over 7000 proteins and up to 10,000 phosphopeptides were identified per cell line, enabling a comprehensive comparative analysis of shared and cell line-specific resistance signatures at the protein level. Data analysis revealed surprisingly few changes in the phosphoproteome but substantial reprogramming of the proteome in most models. Beyond known adaptations such as the overexpression of the PI target PSMB5 and the drug efflux transporter ABCB1, we identified the oxidoreductases NQO1 and NQO2 as significantly upregulated proteins under chronic proteotoxic stress across several models. Pharmacological follow up in PI resistant AMO-1 cells showed that NQO2 inhibition by imatinib fully restored CFZ sensitivity, validating NQO2 as a contributor to resistance formation in this model system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaDrug Resistance, NeoplasmProteasome InhibitorsProteomeQuinone ReductasesHumansCell Line, TumorBortezomibProteomicsProteasome Endopeptidase ComplexOligopeptidesNAD(P)H Dehydrogenase (Quinone)

Stichwörter der Autor:innen

ABCB1NQO1NQO2multiple myelomaphosphoproteomicsproteasome inhibitor resistancequantitative proteomics

Substanzen

Proteasome InhibitorsProteomeNRH - quinone oxidoreductase2BortezomibQuinone ReductasesProteasome Endopeptidase ComplexcarfilzomibOligopeptidesNAD(P)H Dehydrogenase (Quinone)NQO1 protein, human

Autor:innen und Institutionen

  • Chair of Proteomics and Bioanalytics, School of Life Sciences, Technical University of Munich, Freising, Germany.
  • Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; Department of Medicine III, Technical University of Munich, School of Medicine and Health, TUM University Hospital, Munich, Germany.
  • Laboratory of Experimental Oncology, Division Oncology and Hematology, HOCH Health Ostschweiz, Cantonal Hospital St Gallen, St. Gallen, Switzerland; Department of Biology, Faculty of Medicine, Masaryk University, Brno,…
  • Laboratory of Experimental Oncology, Division Oncology and Hematology, HOCH Health Ostschweiz, Cantonal Hospital St Gallen, St. Gallen, Switzerland.
  • Chair of Proteomics and Bioanalytics, School of Life Sciences, Technical University of Munich, Freising, Germany; Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), Technical University of Munich, Freising, Germ…

Förderung

  • German Research Foundation

Zitieren

APA

Lee, C. Y., Han, S., Haertle, L., Munawar, U., Vogt, C., Streubel, J., Besse, A., Besse, L., Driessen, C., Einsele, H., Waldschmidt, J., Kortüm, M., & Kuster, B. (2026). Proteome Profiling Reveals NQO2 Activity Contributing to Proteasome Inhibitor Resistance in Multiple Myeloma Cell Lines. Molecular & Cellular Proteomics, 25(8), 101615. https://doi.org/10.1016/j.mcpro.2026.101615

Vancouver

Lee CY, Han S, Haertle L, Munawar U, Vogt C, Streubel J, et al. Proteome Profiling Reveals NQO2 Activity Contributing to Proteasome Inhibitor Resistance in Multiple Myeloma Cell Lines. Molecular & Cellular Proteomics. 2026;25(8):101615. doi:10.1016/j.mcpro.2026.101615

BibTeX
@article{Lee2026,
  author = {Lee, Chien-Yun and Han, Seungbin and Haertle, Larissa and Munawar, Umair and Vogt, Cornelia and Streubel, Johanna and Besse, Andrej and Besse, Lenka and Driessen, Christoph and Einsele, Hermann and Waldschmidt, Johannes and Kortüm, Martin and Kuster, Bernhard},
  title = {Proteome Profiling Reveals NQO2 Activity Contributing to Proteasome Inhibitor Resistance in Multiple Myeloma Cell Lines},
  journal = {Molecular & Cellular Proteomics},
  year = {2026},
  volume = {25},
  number = {8},
  pages = {101615},
  doi = {10.1016/j.mcpro.2026.101615}
}
Kostenlos starten →